Total n (%) N = 1525 | SVR achieved n (%) N = 1374 | Unadjusted OR and 95% CI | Adjusted OR and 95% CI | |
---|---|---|---|---|
Age group | ||||
18–30 | 7 | 7 (100.00) | – | |
31–45 | 411 | 393 (95.62) | 1 | |
46–60 | 986 | 862 (87.42) | 0.32 (0.19, 0.53) | |
> 60 | 121 | 112 (92.56) | 0.57 (0.25, 1.30) | |
Gender | ||||
Male | 1450 | 1300 (89.66) | 1 | |
Female | 75 | 74 (98.67) | 8.54 (1.18, 61.87) | |
Fibrosis stage | ||||
F4 | 892 | 764 (85.65) | 1 | 1 |
F3 or F3/F4 | 633 | 610 (96.37) | 4.44 (2.82, 7.01) | 4.18 (2.64, 6.61) |
Treatment regimen | ||||
SOF/RBV | 566 | 449 (79.33) | 1 | 1 |
SOF/INF/RBV | 959 | 925 (96.45) | 7.09 (4.76, 10.56) | 6.72 (4.49, 10.06) |